MedPath

SIMNAD, VIRGINIA M.D.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis

Conditions
Multiple Sclerosis
First Posted Date
2013-03-14
Last Posted Date
2018-02-01
Lead Sponsor
Simnad, Virginia, M.D.
Target Recruit Count
36
Registration Number
NCT01811290
Locations
🇺🇸

MS Center at Evergreen Health, Kirkland, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath